Marialuigia Fantacuzzi

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Histone Deacetylase

Helicobacter Pylori

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Marialuigia Fantacuzzi, Mariangela Agamennone
Computational Methods in the Design of Anticancer Drugs. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Marialuigia Fantacuzzi, Roberto Paciotti, Mariangela Agamennone
A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Marialuigia Fantacuzzi, Mariangela Agamennone
Computational Methods in the Design of Anticancer Drugs. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Marialuigia Fantacuzzi, Roberto Paciotti, Mariangela Agamennone
A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Marialuigia Fantacuzzi, Roberto Paciotti, Mariangela Agamennone
A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Marialuigia Fantacuzzi, Ilaria D'Agostino, Simone Carradori, Francesco Liguori, Fabrizio Carta, Mariangela Agamennone, Andrea Ageli, Filomena Sannio, Jean Denis Docquier, Clemente Capasso, Claudiu T Supuran
Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Barbara De Filippis, Marialuigia Fantacuzzi, Alessandra Ammazzalorso
Anticancer Activity of Natural Products and Related Compounds. International journal of molecular sciences 24 (22) (2023)
Germán Benito, Ilaria D'Agostino, Simone Carradori, Marialuigia Fantacuzzi, Mariangela Agamennone, Valentina Puca, Rossella Grande, Clemente Capasso, Fabrizio Carta, Claudiu T Supuran
Erlotinib-containing benzenesulfonamides as anti- Helicobacter pylori agents through carbonic anhydrase inhibition. Future medicinal chemistry (2023)
Cristina Maccallini, Alessandra Ammazzalorso, Barbara De Filippis, Marialuigia Fantacuzzi, Letizia Giampietro, Rosa Amoroso
HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Mariangela Agamennone, Marialuigia Fantacuzzi, Simone Carradori, Anél Petzer, Jacobus P Petzer, Andrea Ageli, Claudiu T Supuran, Grazia Luisi
Coumarin-Based Dual Inhibitors of Human Carbonic Anhydrases and Monoamine Oxidases Featuring Amino Acyl and ( Pseudo )-Dipeptidyl Appendages: In Vitro and Computational Studies. Molecules (Basel, Switzerland) 27 (22) (2022)
Mariangela Agamennone, Marialuigia Fantacuzzi, Giovanni Vivenzio, Maria Carmina Scala, Pietro Campiglia, Fabiana Superti, Marina Sala
Antiviral Peptides as Anti-Influenza Agents. International journal of molecular sciences 23 (19) (2022)
Simone Carradori, Marialuigia Fantacuzzi, Alessandra Ammazzalorso, Andrea Ageli, Barbara De Filippis, Salvatore Galati, Anél Petzer, Jacobus P Petzer, Giulio Poli, Tiziano Tuccinardi, Mariangela Agamennone, Claudiu T Supuran
Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? Molecules (Basel, Switzerland) 27 (22) (2022)
Alessandra Ammazzalorso, Marialuigia Fantacuzzi
Anticancer Inhibitors. Molecules (Basel, Switzerland) 27 (14) (2022)
Marialuigia Fantacuzzi, Rosa Amoroso, Alessandra Ammazzalorso
PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection. Biology 11 (1) (2022)
Rosa Amoroso, Laura De Lellis, Rosalba Florio, Nazaret Moreno-Rodriguez, Mariangela Agamennone, Barbara De Filippis, Letizia Giampietro, Cristina Maccallini, Inmaculada Fernández, Rocío Recio, Allessandro Cama, Marialuigia Fantacuzzi, Alessandra Ammazzalorso
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis. Pharmaceuticals (Basel, Switzerland) 15 (8) (2022)
Alessandra Ammazzalorso, Mariangela Agamennone, Barbara De Filippis, Marialuigia Fantacuzzi
Development of CDK4/6 Inhibitors: A Five Years Update. Molecules (Basel, Switzerland) 26 (5) (2021)
Marialuigia Fantacuzzi, Marialucia Gallorini, Nicola Gambacorta, Alessandra Ammazzalorso, Zeineb Aturki, Marwa Balaha, Simone Carradori, Letizia Giampietro, Cristina Maccallini, Amelia Cataldi, Nicolotti Orazio, Rosa Amoroso, Barbara De Filippis
Design, Synthesis and Biological Evaluation of Aromatase Inhibitors Based on Sulfonates and Sulfonamides of Resveratrol. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Cristina Maccallini, Lisa Marinelli, Patrick Indorf, Ivana Cacciatore, Marialuigia Fantacuzzi, Bernd Clement, Antonio Di Stefano, Rosa Amoroso
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential. ChemMedChem 15 (22) (2020)
Pasquale Linciano, Barbara De Filippis, Alessandra Ammazzalorso, Pasquale Amoia, Felisa Cilurzo, Marialuigia Fantacuzzi, Letizia Giampietro, Cristina Maccallini, Charlotte Petit, Rosa Amoroso
Druggability profile of stilbene-derived PPAR agonists: determination of physicochemical properties and PAMPA study. MedChemComm 10 (11) (2019)
Marialucia Gallorini, Cristina Maccallini, Alessandra Ammazzalorso, Pasquale Amoia, Barbara De Filippis, Marialuigia Fantacuzzi, Letizia Giampietro, Amelia Cataldi, Rosa Amoroso
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro. International journal of molecular sciences 20 (3) (2019)